606
Views
26
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Voriconazole: a novel treatment option for cryptococcal meningitis

, , , , , , & show all
Pages 694-700 | Received 19 Oct 2014, Accepted 15 Apr 2015, Published online: 23 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bhagteshwar Singh, Ahmad Lodhi, Cameron Choi, Alec Bonington & Chris Kosmidis. (2017) Use of voriconazole in non-meningeal cryptococcosis. Infectious Diseases 49:9, pages 702-704.
Read now
Shan-Shan Li, Xin-Yue Tang, Sheng-Guo Zhang, Shun-Lan Ni, Nai-Bin Yang & Ming-Qin Lu. (2016) Voriconazole combined with low-dose amphotericin B liposome for treatment of cryptococcal meningitis. Infectious Diseases 48:7, pages 563-565.
Read now

Articles from other publishers (24)

Handan Zhao, Yanqiu Lu, Shan Li, Jiangying Qin, Miaomiao Xu, Hui Ye, Zongxing Yang, Jianfeng Rao, Guochun Chen, Feifei Su, Zhiliang Hu & Lijun Xu. (2023) Voriconazole plus flucytosine is not superior to amphotericin B deoxycholate plus flucytosine as an induction regimen for cryptococcal meningitis treatment. Mycoses 67:1.
Crossref
Zi-Qiang Zheng, Chao-Wen Yang & Hong-Xia Liu. (2023) Pharmaceutical Care for Premature Infants with Candida Albicans Infection of the Central Nervous System. International Journal of Pediatrics and Child Health 11, pages 86-90.
Crossref
Thomas C. McHale, David R. Boulware, John Kasibante, Kenneth Ssebambulidde, Caleb P. Skipper & Mahsa Abassi. (2023) Diagnosis and management of cryptococcal meningitis in HIV-infected adults. Clinical Microbiology Reviews.
Crossref
D. V. Kapustin, E. I. Krasnova, N. I. Khokhlova, O. M. Shishkova & L. L. Pozdnyakova. (2023) Modern aspects of central nervous system damage in patients with HIV infection (literature review). Journal Infectology 15:3, pages 15-28.
Crossref
Keli Jaqueline Staudt, Bruna Bernar Dias, Izabel Almeida Alves, Bénédicte Lelièvre, Jean-Philippe Bouchara & Bibiana Verlindo de Araújo. (2023) Modeling and Simulation as a Tool to Assess Voriconazole Exposure in the Central Nervous System. Pharmaceutics 15:7, pages 1781.
Crossref
Anna K Person, Brenda Crabtree-Ramirez, Ahra Kim, Valdiléa Veloso, Fernanda Maruri, Gilles Wandeler, Matthew Fox, Richard Moore, M John Gill, Darma Imran, Kinh Van Nguyen, Elizabeth Nalitya, Winnie Muyindike, Bryan E Shepherd & Catherine C McGowan. (2023) Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View. Clinical Infectious Diseases 76:12, pages 2116-2125.
Crossref
Matthew R. Osborn, Andrej Spec & Patrick B. Mazi. (2023) Management of HIV-Associated Cryptococcal Meningitis. Current Fungal Infection Reports 17:2, pages 124-131.
Crossref
Jie Xu, Haibo Liu, Fang Liu, Yingzhi Luo, Rui Yang, Qingtao Kong & Hong Sang. (2022) IL-9 plays a protective role on host defense against the infection of Cryptococcus neoformans. Journal of Medical Mycology 32:4, pages 101297.
Crossref
Ting Zhao, Xiaolei Xu, Yushan Wu, Wei Zhang, Qin Zeng, Yanqiu Lu, Tongtong Yang, Guoqiang Zhou, Jianhua Yu, Ke Lan, Vijay Harypursat & Yaokai Chen. (2022) Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China. BMC Infectious Diseases 22:1.
Crossref
Hang Li, Xiaojing Li, Lei Zhang, Wenjie Fang, Keming Zhang, Amir Arastehfar, Macit Ilkit, Dongying Hu, Xianzhen Chen, Huiwei Wang, Liyan Ling, Jianjun Lin, Bin Xu, Wanqing Liao, Weihua Pan & Qilong Zhang. (2021) The clinical profiles and outcomes of HIV-negative cryptococcal meningitis patients in type II diabetes mellitus. BMC Infectious Diseases 21:1.
Crossref
Brendan O’Kelly, Aia Mohamed, Colm Bergin, Fiona Lyons, Thomas R. Rogers, Brian O’Connell & Emma Devitt. (2021) Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV. Journal of Fungi 7:6, pages 425.
Crossref
Weie Huang, Tiantian Li, Changjing Zhou, Fanglin Wei, Cunwei Cao & Jianning Jiang. (2021) Voriconazole Versus Amphotericin B as Induction Therapy for Talaromycosis in HIV/AIDS Patients: A Retrospective Study. Mycopathologia 186:2, pages 269-276.
Crossref
Markus Ruhnke, Oliver A. Cornely, Martin Schmidt‐Hieber, Nael Alakel, Boris Boell, Dieter Buchheidt, Maximilian Christopeit, Justin Hasenkamp, Werner J. Heinz, Marcus Hentrich, Meinolf Karthaus, Michael Koldehoff, Georg Maschmeyer, Jens Panse, Olaf Penack, Jan Schleicher, Daniel Teschner, Andrew John Ullmann, Maria Vehreschild, Marie Lilienfeld‐Toal, Florian Weissinger & Stefan Schwartz. (2020) Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Mycoses 63:7, pages 653-682.
Crossref
Cristina de Castro Spadari, Fernanda Walt Mendes da Silva de Bastiani, Pietro Bruno Bautista Pisani, Analy Salles de Azevedo Melo & Kelly Ishida. (2019) Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis. Archives of Microbiology 202:4, pages 773-784.
Crossref
Meifang Yang, Xuan Zhang, Jianhua Hu, Hong Zhao & Lanjuan Li. (2019) Cryptococcosis in Patients following Kidney Transplantation: A 9-Year Retrospective Clinical Analysis at a Chinese Tertiary Hospital. BioMed Research International 2019, pages 1-7.
Crossref
Lijun Xu, Xinyue Zhang, Yongzheng Guo, Ran Tao, Xiahong Dai, Zongxing Yang, Ying Huang, Biao Zhu & Yan Xu. (2019) Unique clinical features of cryptococcal meningitis among Chinese patients without predisposing diseases against patients with predisposing diseases. Medical Mycology 57:8, pages 944-953.
Crossref
Ravindra Kumar & Rajrani Ruhel. 2019. Recent Developments in Fungal Diseases of Laboratory Animals. Recent Developments in Fungal Diseases of Laboratory Animals 131 148 .
Ahmad Mourad & John Perfect. (2018) Present and Future Therapy of Cryptococcus Infections. Journal of Fungi 4:3, pages 79.
Crossref
Ahmad Mourad & John R Perfect. (2018) The war on cryptococcosis: A Review of the antifungal arsenal. Memórias do Instituto Oswaldo Cruz 113:7.
Crossref
Joveeta Joseph, Savitri Sharma & Raja Narayanan. (2018) Endogenous Cryptococcus neoformans endophthalmitis with subretinal abscess in a HIV-infected man. Indian Journal of Ophthalmology 66:7, pages 1015.
Crossref
Junyan Qu, Taoyou Zhou, Cejun Zhong, Rong Deng & Xiaoju L?. (2017) Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study. BMC Infectious Diseases 17:1.
Crossref
Izabel Almeida Alves, Keli Jaqueline Staudt, Carolina de Miranda Silva, Graziela de Araujo Lock, Teresa Dalla Costa & Bibiana Verlindo de Araujo. (2017) Influence of Experimental Cryptococcal Meningitis in Wistar Rats on Voriconazole Brain Penetration Assessed by Microdialysis. Antimicrobial Agents and Chemotherapy 61:7.
Crossref
Lauren N. Bowen, Bryan Smith, Daniel Reich, Martha Quezado & Avindra Nath. (2016) HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nature Reviews Neurology 12:11, pages 662-674.
Crossref
niumengqi Niu, Zhenzhen Bai, Liang Dong, Wei Zheng, Xialing Wang, Nannan Dong, Si Tian & Kebin Zeng. (2022) A Novel Diagnostic Prediction Model to Distinguish Tuberculous Meningitis and Cryptococcal Meningitis. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.